Alira Health

Alira Health

BIO International Convention

June 3 - 6, 2024 | San Diego, California, USA

We are thrilled to join the Bio International Convention, the industry’s premier event that hosts thousands from across the global biotech ecosystem.

Meet our delegates on-site to learn how we can help you to build a strong development plan, create a powerful case for funding, and effectively execute to bring your innovation to patients. Our expert team has extensive strategic and technical experience with biotech needs including planning, funding, and executing.

One of our delegates, Brad Ship, will join the panel “Building Capacities in the Industry for Secondary Uses of Health Data: The EHDS Framework” hosted by our partner Biocat, strategic stakeholder and catalyst for promoting, transforming, and projecting the Catalan life sciences and health innovation ecosystem, known as the BioRegion of Catalonia.

Published on:
May 15, 2023
Join Us for the Panel “Building Capacities in the Industry for Secondary Uses of Health Data: The EHDS Framework”

June 03 | 1:45 – 2:45 PDT

On May 3, 2022, the European Commission published its draft regulation on the EHDS. This proposal aims to achieve two main objectives. The first is to improve the provision of cross-border healthcare in the EU, regardless of the patient’s location in Member States. The second is to enable the secondary use of electronic health data by researchers, companies, innovators, and public institutions (data users). This session, chaired by the Council of European BioRegions, representing over 40 health innovation ecosystems in Europe, brings together experts from industry, the European Commission, clinical institutions, and health data experts to discuss the talent needs and skills gaps to fulfill industry’s expectations.

About Our Speaker

Brad Ship

Partner Brad Ship is a Partner at Alira Health with nearly 20 years of management consulting experience. He specializes in providing strategic analysis and guidance to life science clients. Brad combines his management and technical sciences backgrounds to drive answers to the industry’s complex business challenges.

Brad’s expertise is evident in his work with clients of all sizes, ranging from top-20 pharmaceutical companies to early-stage emerging biotechs. He recognizes that each company has unique demands and requirements, and he tailors his approach to provide the most effective solutions.
Brad has experience in multiple therapeutic areas, including oncology, rare diseases, immunology, neurology, ophthalmology, dermatology, and other specialty markets. He is one of Alira Health’s leading experts on rare diseases and cell and gene therapies.

Brad helps clients with strategic advice in biotech corporate strategy, new product strategy, business case assessment and valuation, portfolio strategy, commercialization, due diligence and BD&L, and US market access and pricing. Brad has a Bachelor of Science in engineering from Lafayette College and a Master of engineering management from Dartmouth College.
Meet Our Delegates

Brad Ship


Alexandra Wollersheim

Partner, Transaction Advisory
Chris Rao

Christopher Rao

Senior Vice President, Clinical Operations
Tabatha Bourgois

Tabatha Bourgois

Business Development Director, Regulatory Affairs 

Drug and Device Development Resources

France Biotech Webinar - Patient Engagement
Tips for Co-Designing with Patients
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.